title: Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
authors.affiliation: Divisione di Nefrologia ed Emodialisi, IRCCS Policlinico S. Matteo, Pavia, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Piazza
authors.forename: G
authors.initials: G
authors.lastname: Villa
authors.forename: F
authors.initials: F
authors.lastname: Galli
authors.forename: S
authors.initials: S
authors.lastname: Segagni
authors.forename: G
authors.initials: G
authors.lastname: Bovio
authors.forename: F
authors.initials: F
authors.lastname: Poggio
authors.forename: L
authors.initials: L
authors.lastname: Picardi
authors.forename: L
authors.initials: L
authors.lastname: Bianco
authors.forename: A
authors.initials: A
authors.lastname: Salvadeo
authors.forename: G
authors.initials: G
authors.lastname: Barosi
mesh_terms: D000368:Aged; D003676:Deferoxamine / Q000627:therapeutic use; D004912:Erythrocytes / Q000378:metabolism; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000378:metabolism; D008297:Male; D011164:Porphyrias / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D011166:Porphyrins / Q000652:urine; D011524:Protoporphyrins / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism
chemical_list: D011166:Porphyrins; D011524:Protoporphyrins; D004921:Erythropoietin; D007501:Iron; D003676:Deferoxamine